By Richard Knox A small head-to-head study of two drugs that fight cholesterol is creating a big buzz at a meeting of heart specialists. The results show that a Merck cholesterol-blocker sold as Zetia (and in a combination pill called Vytorin) was inferior
Read More...
Read the complete post at http://www.npr.org/blogs/health/2009/11/doubts_grow_about_zetia_vytori.html?ft=1&f=103537970
Posted
Nov 16 2009, 08:58 AM
by
NPR Blogs: Shots - Health News